Irish Cancer Society’s Clinician Research Development Fellowship 2022
A key priority in the new Irish Cancer Society strategy 2020-2025 is ensuring that Irish patients benefit from world-class cancer research and expertise. Central to this focus is fostering and cultivating research talent to ensure that Ireland is in a position to attract and retain world-class cancer research leaders who will drive evidence-based improvements in patient care.
As part of this commitment, the Irish Cancer Society wishes to invite eligible doctors training in any oncology-related discipline*, preferably those at Registrar or Specialist Registrar level, to submit an application for the Irish Cancer Society’s Clinician Research Development Fellowship 2022.
As called out in the 2017 National Cancer Strategy, the Irish Cancer Society recognises that cancer clinicians require support at this pivotal time in their training to develop as competitive cancer researchers and be in a position to undertake and drive world-class cancer research in Ireland in future.
Therefore, the purpose of the Irish Cancer Society’s Clinician Research Development Fellowship 2022 is to provide the opportunity for Registrars or Specialist Registrars to develop cancer research experience.
Ideally the candidate will be aligned with an Irish Post-Graduate Training Body and enrolled on a HST/SpR Scheme. However, this is not a mandatory requirement, and applications from candidates undertaking a parallel training path will be accepted provided they are strongly supported by a clinical mentor.
The funding available can be used for a variety of activities, once appropriately justified. The successful applicant of this award could, for example, use this funding for salary, enabling them to spend some time away from clinical and administrative commitments over their training to focus on developing and growing an important aspect of Irish cancer research, such as writing and developing clinical trial applications.
A maximum of €8,000 each year could alternatively be used towards M.D. or Ph.D. enrolment fees. This is intended to be a transformative investment for a clinician who has already demonstrated that they are passionate about undertaking active, patient-focused cancer research, but needs the extra support to enable them to accelerate their trajectory to leading and directing research based in Ireland.
*Please see the guidelines for applicants for more information regarding oncology-related disciplines and other important eligibility criteria.
The maximum total funding available is €120,000. The funding period is 24 – 48 months (i.e. maximum of €120,000 over 4 years), once appropriately justified.
Please note that this award can provide funding for a variety of research activities, e.g. salary, running costs associated with a specific research project(s), training and dissemination costs, PPI costs, M.D. or Ph.D. fees etc.
How to apply
Applications must be completed and submitted through the Irish Cancer Society Gateway Grant Tracker online system. In order to submit an online application you are required to register at the following address: https://grants.cancer.ie.
Deadline for applications: 3.00pm, Tuesday, 1st March 2022
|3:00 pm, Tuesday 1 March 2022||Deadline for online Full Application submission|
|March 2022||Review of applications|
|April 2022||Award announced|
* Dates are subject to change. Applicants must be available to attend the interview online.